Missense mutations of the glycine decarboxylase gene (Gldc) are associated clinically with a metabolic disorder, non‐ketotic hyperglycinemia (NKH) and neural tube defects (NTDs) such as exencephaly. This evidence concerns the gene GLDC and metabolic disease.